Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Bucher

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patientsA Hänsel, H C Bucher, R Nüesch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Systematic review on the risk and benefit of different cholesterol-lowering interventionsH C Bucher, L E Griffith, G H Guyatt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapyA C Guex, A J Radziwill, H C Bucher
Journal of HIV Therapy|August 15, 2001
The use of lipid-lowering agents in HIV-infected patientsF Meienberg, E Battegay, H C Bucher, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
BMJ (Clinical Research Ed.)|July 7, 2000
Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trialsH C Bucher, P Hengstler, C Schindler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patientsH C Bucher, L Griffith, G H Guyatt, et al.
Praxis|January 5, 2002
[Hospitalizations in a cohort of 175 severely drug-addicted patients of a medically managed opiate withdrawal project]M Hoffmann, P Haller, H C Bucher, et al.
Praxis|April 9, 1997
[Evidence-based medicine: approach to a more rational medicine. Arbeitsgemeinschaft Cochrane Collaboration Schweiz]H C Bucher, M Egger, J G Schmidt, et al.
Journal of Clinical Epidemiology|June 1, 1997
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trialsH C Bucher, G H Guyatt, L E Griffith, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patientsA Hänsel, H C Bucher, R Nüesch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Systematic review on the risk and benefit of different cholesterol-lowering interventionsH C Bucher, L E Griffith, G H Guyatt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapyA C Guex, A J Radziwill, H C Bucher
Journal of HIV Therapy|August 15, 2001
The use of lipid-lowering agents in HIV-infected patientsF Meienberg, E Battegay, H C Bucher, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996
Incidence of disseminated histoplasmosis in HIV-infected patients in SwitzerlandH C Bucher, K Gyr, B Ledergerber, et al.
BMJ (Clinical Research Ed.)|July 7, 2000
Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trialsH C Bucher, P Hengstler, C Schindler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patientsH C Bucher, L Griffith, G H Guyatt, et al.
Praxis|January 5, 2002
[Hospitalizations in a cohort of 175 severely drug-addicted patients of a medically managed opiate withdrawal project]M Hoffmann, P Haller, H C Bucher, et al.
Praxis|April 9, 1997
[Evidence-based medicine: approach to a more rational medicine. Arbeitsgemeinschaft Cochrane Collaboration Schweiz]H C Bucher, M Egger, J G Schmidt, et al.
Journal of Clinical Epidemiology|June 1, 1997
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trialsH C Bucher, G H Guyatt, L E Griffith, et al.
Pageof 9